ArticleJCO precision oncology2022

Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.

Pat W Whitworth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.